Does a One-Site CDMO Make a Difference in Drug Development?
A guide to the advantages and disadvantages of one-site versus multi-site CDMOs.
This guide explores whether the physical location of a CDMO becomes part of selection criteria and compares one-site CDMOs with multi-site and global CDMOs for small to medium-sized biotechs.
This guide explores whether the physical location of a CDMO becomes part of selection criteria and compares one-site CDMOs with multi-site and global CDMOs for small to medium-sized biotechs.
Benefits of a One-Site Model
Co-located teams reduce handoffs, speed communication and give sponsors a single point of contact for development and manufacturing.
Multi-Site and Global Considerations
Larger networks offer scale and geographic reach but can introduce complexity in coordination and transfer.
Choosing the Right Fit
Program complexity, timelines and sponsor size should guide the decision between one-site and multi-site partners.
Download This White Paper
Biotechnology Media Insights
Continue to Biotechnology Media Insights to access this white paper.